Webinar 9 | Women in Interventional Cardiology: Complex Bifurcation Cases-Antithrombotic Drugs for Acute Coronary Syndromes in Women

Antithrombotic Drugs for Acute Coronary Syndromes in Women

Video Transcription

Video Summary

This discussion highlights the unique challenges and treatment gaps women face with acute coronary syndrome (ACS), emphasizing biological, anatomical, and hormonal differences that affect diagnosis, therapy, and prognosis. Women often receive less guideline-directed antithrombotic therapy and are underrepresented in clinical trials, limiting sex-specific insights. The recent consensus paper calls for sex-adjusted antithrombotic strategies and improved female inclusion in research. It advocates tailored dosing, radial access use, and awareness to reduce undertreatment and complications. The dialogue underscores the need for gender-sensitive medicine to improve outcomes for women with ACS, stressing tailored care and better clinical trial representation.

Keywords

acute coronary syndrome

women's cardiovascular health

sex-specific treatment

antithrombotic therapy

gender-sensitive medicine